242 related articles for article (PubMed ID: 19279217)
1. A tumor suppressor function for caspase-2.
Ho LH; Taylor R; Dorstyn L; Cakouros D; Bouillet P; Kumar S
Proc Natl Acad Sci U S A; 2009 Mar; 106(13):5336-41. PubMed ID: 19279217
[TBL] [Abstract][Full Text] [Related]
2. Caspase-2 deficiency promotes aberrant DNA-damage response and genetic instability.
Dorstyn L; Puccini J; Wilson CH; Shalini S; Nicola M; Moore S; Kumar S
Cell Death Differ; 2012 Aug; 19(8):1288-98. PubMed ID: 22498700
[TBL] [Abstract][Full Text] [Related]
3. Genetic deletion of caspase-2 accelerates MMTV/c-neu-driven mammary carcinogenesis in mice.
Parsons MJ; McCormick L; Janke L; Howard A; Bouchier-Hayes L; Green DR
Cell Death Differ; 2013 Sep; 20(9):1174-82. PubMed ID: 23645210
[TBL] [Abstract][Full Text] [Related]
4. Tumor-suppressing function of caspase-2 requires catalytic site Cys-320 and site Ser-139 in mice.
Ren K; Lu J; Porollo A; Du C
J Biol Chem; 2012 Apr; 287(18):14792-802. PubMed ID: 22396545
[TBL] [Abstract][Full Text] [Related]
5. Caspase-2 as a tumour suppressor.
Puccini J; Dorstyn L; Kumar S
Cell Death Differ; 2013 Sep; 20(9):1133-9. PubMed ID: 23811850
[TBL] [Abstract][Full Text] [Related]
6. Caspase-2: killer, savior and safeguard--emerging versatile roles for an ill-defined caspase.
Krumschnabel G; Manzl C; Villunger A
Oncogene; 2009 Sep; 28(35):3093-6. PubMed ID: 19581929
[TBL] [Abstract][Full Text] [Related]
7. An unexpected role for caspase-2 in neuroblastoma.
Dorstyn L; Puccini J; Nikolic A; Shalini S; Wilson CH; Norris MD; Haber M; Kumar S
Cell Death Dis; 2014 Aug; 5(8):e1383. PubMed ID: 25144718
[TBL] [Abstract][Full Text] [Related]
8. Impaired TNFalpha-induced A20 expression in E1A/Ras-transformed cells.
Huang HL; Yeh WC; Lai MZ; Mirtsos C; Chau H; Chou CH; Benchimol S
Br J Cancer; 2009 Nov; 101(9):1555-64. PubMed ID: 19826422
[TBL] [Abstract][Full Text] [Related]
9. Caspase-2 is required for cell death induced by cytoskeletal disruption.
Ho LH; Read SH; Dorstyn L; Lambrusco L; Kumar S
Oncogene; 2008 May; 27(24):3393-404. PubMed ID: 18193089
[TBL] [Abstract][Full Text] [Related]
10. Tumor prone phenotype of mice deficient in a novel apoptosis-inducing gene, drs.
Tambe Y; Yoshioka-Yamashita A; Mukaisho K; Haraguchi S; Chano T; Isono T; Kawai T; Suzuki Y; Kushima R; Hattori T; Goto M; Yamada S; Kiso M; Saga Y; Inoue H
Carcinogenesis; 2007 Apr; 28(4):777-84. PubMed ID: 17088259
[TBL] [Abstract][Full Text] [Related]
11. A direct link between expression of urokinase plasminogen activator receptor, growth rate and oncogenic transformation in mouse embryonic fibroblasts.
Mazzieri R; Furlan F; D'Alessio S; Zonari E; Talotta F; Verde P; Blasi F
Oncogene; 2007 Feb; 26(5):725-32. PubMed ID: 16878153
[TBL] [Abstract][Full Text] [Related]
12. Apaf-1 and caspase-9 do not act as tumor suppressors in myc-induced lymphomagenesis or mouse embryo fibroblast transformation.
Scott CL; Schuler M; Marsden VS; Egle A; Pellegrini M; Nesic D; Gerondakis S; Nutt SL; Green DR; Strasser A
J Cell Biol; 2004 Jan; 164(1):89-96. PubMed ID: 14709542
[TBL] [Abstract][Full Text] [Related]
13. Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53.
Valente LJ; Grabow S; Vandenberg CJ; Strasser A; Janic A
Oncogene; 2016 Jul; 35(29):3866-71. PubMed ID: 26640149
[TBL] [Abstract][Full Text] [Related]
14. Involvement of p53 and p21 in cellular defects and tumorigenesis in Atm-/- mice.
Xu Y; Yang EM; Brugarolas J; Jacks T; Baltimore D
Mol Cell Biol; 1998 Jul; 18(7):4385-90. PubMed ID: 9632822
[TBL] [Abstract][Full Text] [Related]
15. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition.
Soengas MS; Alarcón RM; Yoshida H; Giaccia AJ; Hakem R; Mak TW; Lowe SW
Science; 1999 Apr; 284(5411):156-9. PubMed ID: 10102818
[TBL] [Abstract][Full Text] [Related]
16. zVAD-fmk upregulates caspase-9 cleavage and activity in etoposide-induced cell death of mouse embryonic fibroblasts.
Rodríguez-Enfedaque A; Delmas E; Guillaume A; Gaumer S; Mignotte B; Vayssière JL; Renaud F
Biochim Biophys Acta; 2012 Aug; 1823(8):1343-52. PubMed ID: 22613767
[TBL] [Abstract][Full Text] [Related]
17. The unpredictable caspase-2: what can it do?
Vakifahmetoglu-Norberg H; Zhivotovsky B
Trends Cell Biol; 2010 Mar; 20(3):150-9. PubMed ID: 20061149
[TBL] [Abstract][Full Text] [Related]
18. Transcriptome profiling of caspase-2 deficient EμMyc and Th-MYCN mouse tumors identifies distinct putative roles for caspase-2 in neuronal differentiation and immune signaling.
Dorstyn L; Hackett-Jones E; Nikolic A; Norris MD; Lim Y; Toubia J; Haber M; Kumar S
Cell Death Dis; 2019 Jan; 10(2):56. PubMed ID: 30670683
[TBL] [Abstract][Full Text] [Related]
19. Cytoplasmic E3 ubiquitin ligase CUL9 controls cell proliferation, senescence, apoptosis and genome integrity through p53.
Li Z; Xiong Y
Oncogene; 2017 Sep; 36(36):5212-5218. PubMed ID: 28481879
[TBL] [Abstract][Full Text] [Related]
20. Transformation-selective apoptotic program triggered by farnesyltransferase inhibitors requires Bin1.
DuHadaway JB; Du W; Donover S; Baker J; Liu AX; Sharp DM; Muller AJ; Prendergast GC
Oncogene; 2003 Jun; 22(23):3578-88. PubMed ID: 12789266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
